Drug
Zafirlukast
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Sputum Discoloured | 23 | 58.0 | 59.6 | signal |
| 2 | Emphysema | 19 | 44.8 | 45.7 | signal |
| 3 | Aphonia | 22 | 37.6 | 38.5 | signal |
| 4 | Pulmonary Mass | 23 | 36.9 | 37.8 | signal |
| 5 | Hiatus Hernia | 19 | 34.9 | 35.7 | signal |
| 6 | Impaired Quality Of Life | 14 | 23.2 | 23.5 | signal |
| 7 | Asthma | 94 | 20.0 | 22.2 | signal |
| 8 | Dyspnoea Exertional | 31 | 19.7 | 20.4 | signal |
| 9 | Wheezing | 47 | 18.9 | 19.9 | signal |
| 10 | Seasonal Allergy | 10 | 16.9 | 17.1 | signal |
| 11 | Respiratory Disorder | 21 | 16.7 | 17.1 | signal |
| 12 | Productive Cough | 31 | 15.6 | 16.1 | signal |
| 13 | Nerve Compression | 5 | 12.9 | 13.0 | signal |
| 14 | Increased Tendency To Bruise | 4 | 10.3 | 10.4 | signal |
| 15 | Spinal Operation | 4 | 7.9 | 7.9 | signal |
| 16 | Sleep Disorder Due To A General Medical Condition | 5 | 7.4 | 7.4 | signal |
| 17 | Dermatitis Atopic | 13 | 6.2 | 6.3 | signal |
| 18 | Injection Site Urticaria | 4 | 3.9 | 3.9 | signal |
| 19 | Device Delivery System Issue | 4 | 3.6 | 3.7 | signal |
| 20 | Injection Site Rash | 4 | 3.1 | 3.1 | no signal |
| 21 | Drug Dose Omission By Device | 3 | 0.9 | 0.9 | no signal |